# CLONAZEPAM
> **ANDA211033** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-06-28
## Drug
- **FDA Application Number:** ANDA211033
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLONAZEPAM
- **Generic name:** CLONAZEPAM
- **Active ingredients:** CLONAZEPAM
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2019-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211033)
---
*AI Analytics · CC0 1.0*